Pastorino and colleagues noted that defining cure in stage II and III colon cancer has been challenging for two reasons: It is difficult to determine the threshold at which the chances of relapse ...

The concept of a cure in oncology, particularly for stage II and III colon cancer (CC), has historically suffered from ...

Colon cancer recurrence risk falls below 0.5% at 6 years post-surgery, offering a practical benchmark for defining cure, according to new research.

The International Myeloma Society, along with the International Myeloma Working Group, convened an Expert Panel with the primary aim of revisiting the definition of HRMM and formulating a practical ...

Entitled “International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma,” the peer-reviewed article, published online on ...

Like with HR-positive patients, researchers found that patients with HR-negative or ER-low tumors lived longer on Enhertu than chemo after nearly three years.

Defining cure in stage II and III colon cancer has been challenging, and has never been systematically studied. In an analysis of 15 randomized trials, colon cancer relapse risk fell to 0.5% by year 6 ...